Abvance Therapeutics has appointed Edward Raskin as CEO

Baxter has appointed Andrew Hider as CEO

Incyte CEO Hervé Hoppenot has retired; he is succeeded by Bill Meury

Sun Pharmaceutical has selected Richard Ascroft to lead its North America operations as CEO, replacing Abhay Gandhi

Virtual Incision has appointed Jim Alecxih as CEO

Vor Bio CEO Robert Ang has stepped down; Jean-Paul Kress has replaced him